Carglumic acid: An additional therapy in the treatment of organic acidurias with hyperammonemia?

35Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background. Hyperammonemia in patients with methylmalonic aciduria (MMA) and propionic aciduria (PA) is caused by accumulation of propionyl-CoA which decreases the synthesis of N-acetyl-glutamate, the natural activator of carbamyl phosphate synthetase 1. A treatment approach with carglumic acid, the structural analogue of N-acetyl-glutamate, has been proposed to decrease high ammonia levels encountered in MMA and PA crises. Case presentation. We described two patients (one with MMA and one with PA) with hyperammonemia at diagnosis. Carglumic acid, when associated with standard treatment of organic acidurias, may be helpful in normalizing the ammonia level. Conclusion. Even though the usual treatment which decreases toxic metabolites remains the standard, carglumic acid could be helpful in lowering plasma ammonia levels over 400 micromol/L more rapidly.

Cite

CITATION STYLE

APA

Levrat, V., Forest, I., Fouilhoux, A., Acquaviva, C., Vianey-Saban, C., & Guffon, N. (2008). Carglumic acid: An additional therapy in the treatment of organic acidurias with hyperammonemia? Orphanet Journal of Rare Diseases, 3(1). https://doi.org/10.1186/1750-1172-3-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free